IDEAYA Biosciences (IDYA) Other Non-Current Liabilities (2018 - 2021)

IDEAYA Biosciences has reported Other Non-Current Liabilities for 4 years, with the latest figure at $6000.0 in Q3 2021.

• Quarterly Other Non-Current Liabilities fell 50.0% year-over-year to $6000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $6000.0 (down 50.0% YoY) and the FY2020 annual result came in at $12000.0, down 64.71% from the prior year.
• Other Non-Current Liabilities was little changed at $6000.0 in Q3 2021 per IDYA's latest filing, from $6000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $113000.0 in Q4 2018 and troughed at $6000.0 in Q2 2021.
• A 4-year average of $29142.9 and a median of $12000.0 in 2020 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2019 and 2021: Other Non-Current Liabilities sank 69.91% in 2019, then plunged 50.0% in 2021.
• Over 4 years, Other Non-Current Liabilities stood at $113000.0 in 2018, then tumbled by 69.91% to $34000.0 in 2019, then plunged by 64.71% to $12000.0 in 2020, then slumped by 50.0% to $6000.0 in 2021.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $6000.0, $6000.0, and $12000.0 for Q3 2021, Q2 2021, and Q4 2020 respectively.